FDA Investigator

Marcelo O Mangalindan

Latest inspection on record: Ambler, United States, May 2018 · records back to 2008

Human DrugsMedical Devices & Rad HealthBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 117 inspections across 109 sites are on record.
  • 151 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2018-05-30.

At a glance

Inspections

117

Sites

109

Observations

151

Career since

Jan 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
CLINLOGIX LLC30 May 2018Medical Devices & Rad Health
Margaret A. Keller PhD25 Apr 2018Biologics
Tris Pharma Inc.16 Apr 2018Human DrugsView 483 →
Giacomina Massaro-Giordano M.D.9 Mar 2018Human DrugsView 483 →
Pascal M. Jabbour, MD19 Dec 2017Medical Devices & Rad HealthView 483 →

Sites inspected

CLINLOGIX LLCAmbler, United States1 insp.
Margaret A. Keller PhDPhiladelphia, United States1 insp.
Tris Pharma Inc.Monmouth Junction, United States1 insp.
Giacomina Massaro-Giordano M.D.Philadelphia, United States1 insp.
Pascal M. Jabbour, MDPhiladelphia, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Marcelo O Mangalindan's 151 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site